Old Web
English
Sign In
Acemap
>
authorDetail
>
A. de Giorgio-Miller
A. de Giorgio-Miller
AstraZeneca
Internal medicine
Medicine
Novelty
Observational study
Obstructive lung disease
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
2020
H. Müllerová
D.K. Finch
Alvar Agusti
M Alacqua
Gary P. Anderson
Richard Beasley
L. Belton
A. de Giorgio-Miller
J. M. Fitzgerald
R Hughes
Ian D. Pavord
David Price
E Rapsomaniki
Mohsen Sadatsafavi
Jørgen Vestbo
Elisabeth H. Bel
Show All
Source
Cite
Save
Citations (0)
Enabling Reductions in Maintenance ICS/LABA Therapy Using as Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study
2020
David J. Jackson
B. D. Kent
Marc Humbert
Liam G. Heaney
Stephanie Korn
M. Keith
Shahid Siddiqui
B. Cook
E Garcia Gil
A. de Giorgio-Miller
Show All
Source
Cite
Save
Citations (2)
Characterization of Patients with Obstructive Lung Disease in the NOVEL Observational LongiTudinal StudY, NOVELTY
2019
Helen K. Reddel
Jørgen Vestbo
Alvar Agusti
Elisabeth H. Bel
Christer Janson
Barry J. Make
David Price
R Hughes
Eleni Rapsomaniki
Niklas Karlsson
Javier Nuevo
S. Rennard
A. de Giorgio-Miller
Marianna Alacqua
M. Gerhardsson de Verdier
Show All
Source
Cite
Save
Citations (1)
1